Cargando…

Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors

BACKGROUND: To report on our experience using a simple optional form to facilitate communication on late effects between the patients and the oncologists during outpatient follow-up and to detail on the spectrum of challenges reported by sarcoma survivors. METHODS: The form was presented for the pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hompland, Ivar, Fauske, Lena, Lorem, Geir Fagerjord, Bruland, Øyvind S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964017/
https://www.ncbi.nlm.nih.gov/pubmed/31969978
http://dx.doi.org/10.1186/s13569-019-0124-3
_version_ 1783488415071731712
author Hompland, Ivar
Fauske, Lena
Lorem, Geir Fagerjord
Bruland, Øyvind S.
author_facet Hompland, Ivar
Fauske, Lena
Lorem, Geir Fagerjord
Bruland, Øyvind S.
author_sort Hompland, Ivar
collection PubMed
description BACKGROUND: To report on our experience using a simple optional form to facilitate communication on late effects between the patients and the oncologists during outpatient follow-up and to detail on the spectrum of challenges reported by sarcoma survivors. METHODS: The form was presented for the patients to complete before their consultation and covered topics related to late effects and unmet needs that the patient wished to discuss with the medical personnel. Logistic regression analysis examined how the distribution of the topics varied with age, gender, diagnosis and type of treatment received. RESULTS: The form was manageable in a busy outpatient clinic. Of the 265 patients that received the form, 236 (89%) returned it. Patients in a palliative setting and those with other diagnosis than bone sarcoma (BS) and soft-tissue sarcoma (STS) were excluded for subsequent analyses. The final study-cohort comprised 160 patients, 54 (34%) with BS and 106 (66%) with STS. Among these, 140 (88%) had late-effect topics they wanted to discuss with their oncologist. Fatigue was raised by 39% of the patients, pain by 29% and impaired mobility by 23%. BS patients raised fatigue more often (P < 0.005) than those with STS. Patients who had undergone multimodal treatment with chemotherapy raised fatigue more frequently (P < 0.001) than those who had only undergone surgery, radiotherapy or both. CONCLUSIONS: A simple form on the long-term consequences of sarcoma treatment achieved a high response rate, was feasible to use in an outpatient clinic and facilitated communication on these issues. Fatigue was the most frequent topic raised and it was raised significantly more often in patients who had undergone chemotherapy.
format Online
Article
Text
id pubmed-6964017
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69640172020-01-22 Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors Hompland, Ivar Fauske, Lena Lorem, Geir Fagerjord Bruland, Øyvind S. Clin Sarcoma Res Research BACKGROUND: To report on our experience using a simple optional form to facilitate communication on late effects between the patients and the oncologists during outpatient follow-up and to detail on the spectrum of challenges reported by sarcoma survivors. METHODS: The form was presented for the patients to complete before their consultation and covered topics related to late effects and unmet needs that the patient wished to discuss with the medical personnel. Logistic regression analysis examined how the distribution of the topics varied with age, gender, diagnosis and type of treatment received. RESULTS: The form was manageable in a busy outpatient clinic. Of the 265 patients that received the form, 236 (89%) returned it. Patients in a palliative setting and those with other diagnosis than bone sarcoma (BS) and soft-tissue sarcoma (STS) were excluded for subsequent analyses. The final study-cohort comprised 160 patients, 54 (34%) with BS and 106 (66%) with STS. Among these, 140 (88%) had late-effect topics they wanted to discuss with their oncologist. Fatigue was raised by 39% of the patients, pain by 29% and impaired mobility by 23%. BS patients raised fatigue more often (P < 0.005) than those with STS. Patients who had undergone multimodal treatment with chemotherapy raised fatigue more frequently (P < 0.001) than those who had only undergone surgery, radiotherapy or both. CONCLUSIONS: A simple form on the long-term consequences of sarcoma treatment achieved a high response rate, was feasible to use in an outpatient clinic and facilitated communication on these issues. Fatigue was the most frequent topic raised and it was raised significantly more often in patients who had undergone chemotherapy. BioMed Central 2020-01-16 /pmc/articles/PMC6964017/ /pubmed/31969978 http://dx.doi.org/10.1186/s13569-019-0124-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hompland, Ivar
Fauske, Lena
Lorem, Geir Fagerjord
Bruland, Øyvind S.
Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
title Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
title_full Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
title_fullStr Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
title_full_unstemmed Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
title_short Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
title_sort use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964017/
https://www.ncbi.nlm.nih.gov/pubmed/31969978
http://dx.doi.org/10.1186/s13569-019-0124-3
work_keys_str_mv AT homplandivar useofasimpleformtofacilitatecommunicationonlongtermconsequencesoftreatmentinsarcomasurvivors
AT fauskelena useofasimpleformtofacilitatecommunicationonlongtermconsequencesoftreatmentinsarcomasurvivors
AT loremgeirfagerjord useofasimpleformtofacilitatecommunicationonlongtermconsequencesoftreatmentinsarcomasurvivors
AT brulandøyvinds useofasimpleformtofacilitatecommunicationonlongtermconsequencesoftreatmentinsarcomasurvivors